Metagenomi, Inc. Common Stock

Metagenomi, Inc. Common Stockverified

MGX

Price:

$1.79

Market Cap:

$67.21M

Metagenomi, Inc., a gene editing biotechnology company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. The company's genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, such as prime editing systems and clustered regularly interspaced short palindromic repeat-associated transposases. It has a strategic collaboration and license agreement with ModernaTX, Inc. focusing on new genome editing system for in vivo human therapeutic applications; a development, option, and license agreement with Affini-T Therapeutics, Inc. to develop and commercialize gene edited T-cell recepto...[Read more]

Industry

Biotechnology

IPO Date

2006-04-06

Stock Exchange

NASDAQ

Ticker

MGX

The ROE as of December 2025 (TTM) for Metagenomi, Inc. Common Stock (MGX) is -38.76%

According to Metagenomi, Inc. Common Stock’s latest financial reports and current stock price. The company's current ROE is -38.76%. This represents a change of 295.05% compared to the average of -9.81% of the last 4 quarters.

Metagenomi, Inc. Common Stock (MGX) Historical ROE (quarterly & annually)

How has MGX ROE performed in the past?

The mean historical ROE of Metagenomi, Inc. Common Stock over the last ten years is -11.93%. The current -38.76% ROE has changed 224.82% with respect to the historical average. Over the past ten years (40 quarters), MGX's ROE was at its highest in in the December 2022 quarter at 19.65%. The ROE was at its lowest in in the March 2022 quarter at -21.14%.

Quarterly (TTM)
Annual

Average

-11.93%

Median

-24.64%

Minimum

-48.79%

Maximum

50.34%

Metagenomi, Inc. Common Stock (MGX) ROE by Quarter and Year

Discovering the peaks and valleys of Metagenomi, Inc. Common Stock ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual ROE = 50.34%

Minimum Annual Increase = -413.73%

Minimum Annual ROE = -48.79%

Quarterly (TTM)
Annual
YearROEChange
2024-33.24%-166.02%
202350.34%-413.73%
2022-16.05%-67.11%

Metagenomi, Inc. Common Stock (MGX) Average ROE

How has MGX ROE performed in the past?

The current ROE of Metagenomi, Inc. Common Stock (MGX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

0.35%

5-year avg

-11.93%

10-year avg

-11.93%

Metagenomi, Inc. Common Stock (MGX) ROE vs. Peers

How is MGX’s ROE compared to its peers?

Metagenomi, Inc. Common Stock’s ROE is greater than Precision BioSciences, Inc. (-213.79%), greater than aTyr Pharma, Inc. (-100.11%), greater than Adverum Biotechnologies, Inc. (-3844.85%), greater than Artiva Biotherapeutics, Inc. (-45.64%), less than Sutro Biopharma, Inc. (861.99%), greater than Quince Therapeutics, Inc. (-186.08%), greater than InflaRx N.V. (-71.27%), greater than Kalaris Therapeutics Inc (-76.00%), greater than Connect Biopharma Holdings Limited (-44.18%), greater than ALX Oncology Holdings Inc. (-115.67%),

Build a custom stock screener for Metagenomi, Inc. Common Stock (MGX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Metagenomi, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Metagenomi, Inc. Common Stock (MGX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Metagenomi, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Metagenomi, Inc. Common Stock's ROE?

How is the ROE calculated for Metagenomi, Inc. Common Stock (MGX)?

What is the highest ROE for Metagenomi, Inc. Common Stock (MGX)?

What is the 3-year average ROE for Metagenomi, Inc. Common Stock (MGX)?

What is the 5-year average ROE for Metagenomi, Inc. Common Stock (MGX)?

How does the current ROE for Metagenomi, Inc. Common Stock (MGX) compare to its historical average?